Saxenda

French regulator fines Novo, Lilly over obesity drug promotion

As Novo Nordisk and Eli Lilly’s rivalry heats up, French regulators are reminding the two obesity drugmakers what happens when promotion goes too far.

Ben Adams May 6, 2026 9:40am

Teva launches first generic version of Novo's GLP-1 Saxenda

Aug 28, 2025 3:45pm

Compounder compounding compounding pharmacy pharmacist

Novo asks FDA to restrict compounding of legacy GLP-1 Victoza

Jan 3, 2025 3:25pm

Novo Nordisk scolded yet again by UK drug marketing watchdog

Sep 26, 2024 10:46am

Novo weight-loss drugs pose risk of stomach problems: study

Oct 6, 2023 12:55pm

Increased demand squeezes supplies of Eli Lilly's Mounjaro—again

Jul 26, 2023 9:57am